Related Experiment Videos
Tuberous sclerosis complex: from Drosophila to human disease
Duojia Pan1, Jixin Dong, Yong Zhang
1Department of Physiology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390-9040, USA. Duojia.Pan@UTSouthwestern.edu
Trends in Cell Biology
|April 23, 2004
Summary
Tuberous sclerosis complex (TSC) is caused by mutations in TSC1/TSC2 genes. These genes form a complex that acts as a GTPase activating protein, regulating cell growth and offering new therapeutic targets for TSC.
Area of Science:
- Molecular Biology
- Genetics
- Cellular Biology
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder causing benign tumor development.
- Mutations in TSC1 or TSC2 tumor suppressor genes underlie TSC.
- The precise molecular functions of TSC1 and TSC2 have remained largely unknown.
Purpose of the Study:
- To review recent findings on the molecular mechanisms of TSC1 and TSC2.
- To highlight the role of the TSC1-TSC2 complex in regulating cell growth.
- To emphasize the utility of Drosophila as a model system for studying TSC.
Main Methods:
- Review of recent studies in Drosophila and mammalian cells.
- Analysis of the TSC1-TSC2 complex's function as a GTPase activating protein (GAP).
- Investigation of Rheb GTPase regulation and its impact on TOR signaling.
Main Results:
- The TSC1-TSC2 complex functions as a GTPase activating protein (GAP) for Rheb.
- Rheb regulates nutrient-stimulated cell growth via TOR signaling.
- This reveals a paradigm for nutrient-sensing tumor suppressors.
Conclusions:
- The TSC1-TSC2 complex's GAP activity against Rheb is a key mechanism in TSC.
- Understanding this pathway offers novel therapeutic strategies for TSC.
- Drosophila serves as a valuable model for elucidating human disease gene functions.